Validity and Reliability of The Turkish Version of Assessment of Burden of COPD Scale

COPD Clinical Trial

Official title:

Validity and Reliability of The Turkish Version of Assessment of Burden of COPD Scale

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03610659
• Other study ID #: ssaka03
• Status: Completed
• Start date: June 23, 2018
• Est. completion date: February 1, 2019

Study information

• Verified date: February 2019
• Source: Bezmialem Vakif University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

In our study, we aimed to evaluate the validity and reliability of the Turkish version of theAssessment of Burden of COPD (ABC) Scale.

Description:

Chronic obstructive pulmonary disease (COPD) is a common pulmonary disease characterized by airway limitation, irreversible, preventable, and treatable (1,2). COPD is a major health problem that affects the entire world and is expected to be the fourth, the seventh, cause of death in 2030 (3). The concept of "holistic assessment of disease burden" is widely used to support the personalized care management of COPD patients. Disease burden; physical, psychological, emotional and / or social burden felt by the patient. When the questionnaires in the literature evaluating the quality of life / health status in COPD patients were examined, it was seen that none of these questionnaires included all aspects of COPD burden definition (4). Clinical COPD Questionnaire (CCQ) is a 10-question questionnaire that assesses COPD burden in most aspects and situations. Assessment of Burden of COPD (ABC) Scale was developed to evaluate the burden of disease in COPD patients by adapting this questionnaire. The ABC scale was formed by combining three items (a short tool for early identification of distress) and a substance that measures fatigue with the questions of the CCQ scale. As a result, a scale of 14 items with 5 fields was formed.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 75
• Est. completion date: February 1, 2019
• Est. primary completion date: December 25, 2018
• Gender: All
• Age group: 18 Years to 99 Years

Eligibility

Inclusion Criteria:

• FEV1/FVC<%70

• To be able to read and understand Turkish

Exclusion Criteria:

• Having undergone a COPD exacerbation in the last 6 weeks

• Having comorbidities affecting ambulance

• Having cognitive disorders

Related Conditions & MeSH terms

• COPD

Locations

Country	Name	City	State
Turkey	Bezmialem Vakif University	Istanbul

Sponsors (1)

Lead Sponsor	Collaborator
Bezmialem Vakif University

Country where clinical trial is conducted

Turkey, 

References & Publications (2)

Goossens LMA, Rutten-van Mölken MPMH, Boland MRS, Donkers B, Jonker MF, Slok AHM, Salomé PL, van Schayck OCP, In 't Veen JCCM, Stolk EA; research team that developed the ABC tool. ABC Index: quantifying experienced burden of COPD in a discrete choice experiment and predicting costs. BMJ Open. 2017 Dec 26;7(12):e017831. doi: 10.1136/bmjopen-2017-017831. — View Citation

Slok AH, Bemelmans TC, Kotz D, van der Molen T, Kerstjens HA, In 't Veen JC, Chavannes NH, Asijee GM, Rutten-van Mölken MP, van Schayck OC. The Assessment of Burden of COPD (ABC) Scale: A Reliable and Valid Questionnaire. COPD. 2016 Aug;13(4):431-8. doi: 10.3109/15412555.2015.1118025. Epub 2016 Jan 20. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Assessment of Burden of COPD (ABC) Scale	The ABC scale is a 14-item newly developed COPD burden assessment questionnaire that the person responds to on their own. The scale includes questions that are objective determinants of COPD disease burden integrated with the health status of the patient. There is a total score and 5 subtitle scores; symptoms (4 items), functional status (4 items), mental condition (2 items), emotional condition (3 items) and fatigue (1 item). Scoring is done between 0 and 6 (0 = no disease burden, 6 = high disease burden).	3 Minutes